Navigation Links
Visualizing virus replication in three dimensions

Dengue fever is the most common infectious disease transmitted by mosquitoes some 100 million people around the world are infected. Researchers at the Hygiene Institute at Heidelberg University Hospital were the first to present a three-dimensional model of the location in the human cell where the virus is reproduced. Their research provides an insight into the exact process of viral replication and serves as a model for other viruses whose replication is still unclear, such as the hepatitis C virus. In addition, it offers new approaches for developing measures to prevent or treat dengue fever. Up to now, neither a vaccine nor a specific antiviral therapy exists.

Professor Dr. Ralf Bartenschlager, director of the Department of Molecular Virology at the Heidelberg Hygiene Institute and his team, working in cooperation with colleagues from the European Molecular Biology Laboratory (EMBL) have published their study in the latest issue of the prestigious journal Cell Host & Microbes.

Viruses do not have a metabolism and cannot produce proteins from their genetic material (RNA or DNA) on their own. They can replicate only inside a host cell but where and how exactly does this take place? The answer to this question is crucial for developing therapy.

Viruses transform human cell membranes for their purposes

Dengue viruses reproduce in what is known as the endoplasmic reticulum, a membrane network interconnected with the nuclear envelope; this is where proteins are synthesized. The dengue virus uses this membrane network and transforms it for its own use.

"We now know that viral RNA is replicated in vesicles in the endoplasmic reticulum and is secreted through tiny pores. We were also able to show that replication of the virus genome and its encapsulation in new virus particles are directly linked," said Professor Bartenschlager. The new virus genomes are secreted through pores into the intracellular space where they are incorporated into pre-stages of viruses and then penetrate the endoplasmic reticulum a second time. There they are enveloped in a membrane that disguises them for the cell so that they can be secreted like normal cellular material. The reproduction cycle can begin again.


Contact: Prof. Dr. Ralf Bartenschlager
University Hospital Heidelberg

Related biology news :

1. Broad Institute researchers introduce next generation tool for visualizing genomic data
2. Novel antibody prevents infection by hepatitis C virus
3. K-State researcher finds 1918 flu resulted in current lineage of H1N1 swine influenza viruses
4. FluChip technology licensed to combat deadly flu virus
5. Findings uncover new details about mysterious virus
6. Minimizing the spread of deadly Hendra virus
7. MDC researchers prevent virus induced myocarditis
8. West Nile virus studies show how star-shaped brain cells cope with infection
9. Catching the common cold virus genome
10. Epstein-Barr virus may be associated with progression of MS
11. Frogs immune system is key in fight against killer virus
Post Your Comments:
Related Image:
Visualizing virus replication in three dimensions
(Date:11/17/2015)... Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and ... of broadly enabling, pressure cycling technology ("PCT")-based sample preparation ... it has received gross proceeds of $745,000 from an ... "Offering"), increasing the total amount raised to date in ... are expected in the near future. ...
(Date:11/12/2015)... BOSTON , Nov. 12, 2015  A golden ... for Duchenne muscular dystrophy (DMD) has provided a new ... Boston Children,s Hospital, the Broad Institute of MIT and ... Brazil . Cell, ... some dogs "escape" the disease,s effects. The Boston Children,s ...
(Date:11/12/2015)... 2015   Growing need for low-cost, easy ... been paving the way for use of biochemical ... analytes in clinical, agricultural, environmental, food and defense ... in medical applications, however, their adoption is increasing ... continuous emphasis on improving product quality and growing ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... CA (PRWEB) , ... November 25, 2015 , ... ... genomics company uBiome, were featured on AngelList early in their initial angel funding ... an AngelList syndicate for individuals looking to make early stage investments in the ...
(Date:11/24/2015)... 2015 /CNW/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended September 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... said Andrew Rae , President & CEO ... not only value enriching for this clinical program, ...
(Date:11/24/2015)... -- --> --> ... Market by Product & Services (Primer, Probe, Custom Oligos, ... End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - Global ... expected to reach USD 1,918.6 Million by 2020 from ... 10.1% during the forecast period. Browse 183 ...
(Date:11/24/2015)... Ltd. (OTCQB: TIKRF) today announced that its Annual General Meeting of Shareholders ... Israel time, at the law offices of Goldfarb Seligman ... Floor, Tel Aviv, Israel . ... to the Board of Directors; , election of Liat ... an amendment to certain terms of options granted to our Chief Executive ...
Breaking Biology Technology: